RU2011109210A - Лекарственная форма, содержащая тетрагидробиоптерин - Google Patents
Лекарственная форма, содержащая тетрагидробиоптерин Download PDFInfo
- Publication number
- RU2011109210A RU2011109210A RU2011109210/15A RU2011109210A RU2011109210A RU 2011109210 A RU2011109210 A RU 2011109210A RU 2011109210/15 A RU2011109210/15 A RU 2011109210/15A RU 2011109210 A RU2011109210 A RU 2011109210A RU 2011109210 A RU2011109210 A RU 2011109210A
- Authority
- RU
- Russia
- Prior art keywords
- dosage form
- tetrahydrobiopterin
- form according
- metabolic precursor
- aqueous solution
- Prior art date
Links
- FNKQXYHWGSIFBK-RPDRRWSUSA-N sapropterin Chemical compound N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 FNKQXYHWGSIFBK-RPDRRWSUSA-N 0.000 title claims abstract 15
- 229960004617 sapropterin Drugs 0.000 title claims abstract 15
- 239000002552 dosage form Substances 0.000 claims abstract 17
- 230000002503 metabolic effect Effects 0.000 claims abstract 13
- 239000002243 precursor Substances 0.000 claims abstract 13
- 239000007864 aqueous solution Substances 0.000 claims abstract 9
- -1 sulfhydryl compound Chemical class 0.000 claims abstract 9
- 239000003963 antioxidant agent Substances 0.000 claims abstract 8
- 230000003078 antioxidant effect Effects 0.000 claims abstract 8
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract 7
- 235000018417 cysteine Nutrition 0.000 claims abstract 7
- 239000012895 dilution Substances 0.000 claims abstract 3
- 238000010790 dilution Methods 0.000 claims abstract 3
- REYLLNRLWCBKCM-YFKPBYRVSA-N (2s)-2-acetamido-4-sulfanylbutanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCS REYLLNRLWCBKCM-YFKPBYRVSA-N 0.000 claims abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims abstract 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims abstract 2
- 229960004308 acetylcysteine Drugs 0.000 claims abstract 2
- YVKSGVDJQXLXDV-BYPYZUCNSA-N ethyl (2r)-2-amino-3-sulfanylpropanoate Chemical compound CCOC(=O)[C@@H](N)CS YVKSGVDJQXLXDV-BYPYZUCNSA-N 0.000 claims abstract 2
- FTURCWPZLPUMLY-YFKPBYRVSA-N ethyl (2s)-2-amino-4-sulfanylbutanoate Chemical compound CCOC(=O)[C@@H](N)CCS FTURCWPZLPUMLY-YFKPBYRVSA-N 0.000 claims abstract 2
- GPBQMUGQGMBCNZ-BYPYZUCNSA-N methyl (2s)-2-amino-4-sulfanylbutanoate Chemical compound COC(=O)[C@@H](N)CCS GPBQMUGQGMBCNZ-BYPYZUCNSA-N 0.000 claims abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims abstract 2
- 150000003839 salts Chemical group 0.000 claims abstract 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims abstract 2
- 201000011252 Phenylketonuria Diseases 0.000 claims 1
- 235000008452 baby food Nutrition 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA1254/2008 | 2008-08-12 | ||
| AT12542008 | 2008-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2011109210A true RU2011109210A (ru) | 2012-09-20 |
Family
ID=41111155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011109210/15A RU2011109210A (ru) | 2008-08-12 | 2009-08-07 | Лекарственная форма, содержащая тетрагидробиоптерин |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110144117A1 (enExample) |
| EP (1) | EP2309983B1 (enExample) |
| JP (1) | JP2011530540A (enExample) |
| ES (1) | ES2736730T3 (enExample) |
| PL (1) | PL2309983T3 (enExample) |
| RU (1) | RU2011109210A (enExample) |
| TR (1) | TR201910287T4 (enExample) |
| WO (1) | WO2010017570A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014202925B2 (en) * | 2013-01-10 | 2015-07-09 | Nutritional Therapeutics, Inc. | Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders |
| EP2926805B1 (en) | 2014-03-31 | 2016-05-18 | Vasopharm GmbH | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions |
| IL266955B2 (en) | 2016-11-29 | 2023-09-01 | Ptc Therapeutics Mp Inc | Polymorphs of spiafatrin and its salts |
| WO2018102314A1 (en) | 2016-11-29 | 2018-06-07 | Censa Pharmaceuticals Inc. | Polymorphic form of sepiapterin |
| WO2019046849A1 (en) * | 2017-09-01 | 2019-03-07 | Censa Pharmaceuticals Inc. | PHARMACEUTICAL COMPOSITION COMPRISING SEPAPTERINE AND USES THEREOF |
| SMT202400430T1 (it) | 2018-05-30 | 2024-11-15 | Ptc Therapeutics Mp Inc | Somministrazione di sepiapterina, senza alcun alimento, per uso in un metodo per incrementare l’esposizione plasmatica di sepiapterina |
| EP3801534A4 (en) | 2018-05-30 | 2022-03-16 | PTC Therapeutics MP, Inc. | COMPOSITIONS AND METHODS TO INCREASE TETRAHYDROBIOPTERIN PLASMA EXPOSURE |
| JP7553906B2 (ja) * | 2018-11-01 | 2024-09-19 | 宏 一瀬 | Ｓｐｒをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61277618A (ja) * | 1985-06-04 | 1986-12-08 | Suntory Ltd | 自閉症治療剤 |
| JP2588191B2 (ja) * | 1987-04-24 | 1997-03-05 | サントリー株式会社 | 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤 |
| DE10260263A1 (de) * | 2002-12-20 | 2004-07-15 | Biocrates Life Sciences Gmbh | Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen |
| WO2005107759A1 (ja) * | 2004-05-11 | 2005-11-17 | Daiichi Asubo Pharma Co., Ltd. | Ｂｈ４反応性高フェニルアラニン血症治療剤 |
| EP2436379A1 (en) * | 2004-11-17 | 2012-04-04 | BioMarin Pharmaceutical Inc. | Stable tablet formulation |
| US20060188492A1 (en) * | 2005-01-13 | 2006-08-24 | Chronorx Llc, An Alaska Limited Liability Company | Topical management of ocular and periocular conditions |
| AU2006245770A1 (en) * | 2005-05-11 | 2006-11-16 | Nycomed Gmbh | Combination of the PDE4 inhibitor roflumilast and a tetrahydrobiopterin derivative |
| DK3461503T3 (da) * | 2007-04-11 | 2022-02-14 | Biomarin Pharm Inc | Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder |
-
2009
- 2009-08-07 ES ES09775591T patent/ES2736730T3/es active Active
- 2009-08-07 PL PL09775591T patent/PL2309983T3/pl unknown
- 2009-08-07 RU RU2011109210/15A patent/RU2011109210A/ru not_active Application Discontinuation
- 2009-08-07 WO PCT/AT2009/000306 patent/WO2010017570A2/de not_active Ceased
- 2009-08-07 TR TR2019/10287T patent/TR201910287T4/tr unknown
- 2009-08-07 JP JP2011522346A patent/JP2011530540A/ja active Pending
- 2009-08-07 US US13/058,625 patent/US20110144117A1/en not_active Abandoned
- 2009-08-07 EP EP09775591.2A patent/EP2309983B1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20110144117A1 (en) | 2011-06-16 |
| WO2010017570A2 (de) | 2010-02-18 |
| EP2309983B1 (de) | 2019-04-24 |
| JP2011530540A (ja) | 2011-12-22 |
| PL2309983T3 (pl) | 2019-09-30 |
| ES2736730T3 (es) | 2020-01-07 |
| EP2309983A2 (de) | 2011-04-20 |
| TR201910287T4 (tr) | 2019-07-22 |
| WO2010017570A3 (de) | 2010-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011109210A (ru) | Лекарственная форма, содержащая тетрагидробиоптерин | |
| US10973786B2 (en) | R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions | |
| US11806324B2 (en) | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies | |
| JP2011530540A5 (enExample) | ||
| ES2861583T3 (es) | Preparación oral de acción rápida que puede aumentar el nivel de arginina en sangre y que comprende citrulina y arginina | |
| JP2015527402A5 (enExample) | ||
| EA201492021A1 (ru) | Антительный состав | |
| HRP20250382T1 (hr) | Farmaceutski pripravak koji sadrži karbetocin | |
| AU2020221569B2 (en) | Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use | |
| AU2020221031B2 (en) | Beta-hydroxybutyrate mixed salt-acid compositions and methods of use | |
| JP2016518404A (ja) | 安定化したペメトレキセド製剤 | |
| RU2015122023A (ru) | Стабилизированная композиция пеметрекседа | |
| ES2605495T3 (es) | Solución de atomoxetina | |
| UA101407C2 (ru) | Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат | |
| US20230201145A1 (en) | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies | |
| US20250025434A1 (en) | S-beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies | |
| ES2224869A1 (es) | Composiciones farmaceuticas con actividad antibiotica. | |
| US10548865B1 (en) | Compositions of citrulline | |
| ES2401402T3 (es) | Comprimidos efervescentes y gránulos efervescentes que contienen tartrato de carnitina | |
| US11419836B2 (en) | Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions | |
| MXPA04004907A (es) | Composiciones de acetaminofen. | |
| MX2009001153A (es) | Formulacion de espuma comestible acuosa en aerosol. | |
| WO2020011753A1 (en) | Compositions for therapeutic uses containing 5-htp and carbidopa | |
| AU2020221916B2 (en) | S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer | |
| RU2014146562A (ru) | Композиция, содержащая альфа-липоевую кислоту и гонокиол, для лечения нейропатий |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20131015 |